NFE2L2 and Alzheimer disease: Preclinical and clinical findings showed that phosphorylated Nrf2 level is increased in human peripheral blood cells of AD patients and in an AD mouse model at various stages as a compensatory mechanism to reduce oxidative stress in AD (Mota et al., 2015).